Adaptimmune Therapeutics PLC (ADAP)
0.8335
+0.03
(+4.21%)
USD |
NASDAQ |
Nov 04, 12:59
Adaptimmune Therapeutics 1 Year Total Returns (Daily): 48.11% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 48.11% |
October 31, 2024 | 34.20% |
October 30, 2024 | 25.55% |
October 29, 2024 | 28.09% |
October 28, 2024 | 34.04% |
October 25, 2024 | 24.01% |
October 24, 2024 | 22.27% |
October 23, 2024 | 30.75% |
October 22, 2024 | 43.36% |
October 21, 2024 | 45.81% |
October 18, 2024 | 43.61% |
October 17, 2024 | 33.78% |
October 16, 2024 | 30.98% |
October 15, 2024 | 34.15% |
October 14, 2024 | 34.01% |
October 11, 2024 | 28.18% |
October 10, 2024 | 29.26% |
October 09, 2024 | 29.69% |
October 08, 2024 | 27.44% |
October 07, 2024 | 27.61% |
October 04, 2024 | 30.72% |
October 03, 2024 | 17.76% |
October 02, 2024 | 16.63% |
October 01, 2024 | 18.13% |
September 30, 2024 | 21.85% |
Date | Value |
---|---|
September 27, 2024 | 22.15% |
September 26, 2024 | 23.29% |
September 25, 2024 | 20.96% |
September 24, 2024 | 24.09% |
September 23, 2024 | 19.88% |
September 20, 2024 | 33.70% |
September 19, 2024 | 38.83% |
September 18, 2024 | 40.45% |
September 17, 2024 | 29.42% |
September 16, 2024 | 29.42% |
September 13, 2024 | 38.18% |
September 12, 2024 | 43.21% |
September 11, 2024 | 34.98% |
September 10, 2024 | 46.88% |
September 09, 2024 | 50.96% |
September 06, 2024 | 43.42% |
September 05, 2024 | 43.04% |
September 04, 2024 | 46.84% |
September 03, 2024 | 53.16% |
August 30, 2024 | 54.88% |
August 29, 2024 | 58.75% |
August 28, 2024 | 56.41% |
August 27, 2024 | 58.97% |
August 26, 2024 | 70.51% |
August 23, 2024 | 48.23% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.82%
Minimum
Nov 15 2019
767.9%
Maximum
Oct 13 2020
18.83%
Average
-31.54%
Median
1 Year Total Returns (Daily) Benchmarks
Biodexa Pharmaceuticals PLC | -93.61% |
Verona Pharma PLC | 145.0% |
NuCana PLC | -86.89% |
Autolus Therapeutics PLC | 18.64% |
Bicycle Therapeutics PLC | 47.95% |